Answers are grounded in this paper and cite their sources.
Apramycin, a new aminocyclitol antibiotic, was tested for antibacterial activity, particularly in comparison with neomycin and streptomycin against potentially sensitive animal pathogens. Of the strains tested 99% were sensitive to apramycin, 93% to neomycin and 48% to streptomycin. Apramycin resistance development in vitro was shown to be gradual.
No takes yet. Share an insight, caveat, or question.
Ryden et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: